Ebola Alert: WHO says the outbreak in eastern Democratic Republic of the Congo remains severe, with hundreds of new cases reported weekly and insecurity disrupting care and tracking. The risk of cross-border spread keeps the crisis relevant for Central African Republic preparedness. Yellow Fever: WHO counted two confirmed cases in the Central African Republic among 67 cases and 18 deaths across nine African countries through October 12. It warns that uneven vaccination and cross-border movement could fuel spread. Deportee Health Concerns: Cuban migrants deported to Bangui report illness, limited access to medicine and malaria diagnoses; those diagnoses have not been independently confirmed. Food and Nutrition: A $7 million Catholic Relief Services project in three conflict-affected towns provided food and livestock support before ending in 2025, as aid groups warn that funding is shrinking.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Ebola Watch: WHO says the outbreak in neighbouring DR Congo remains deeply concerning, with 400–500 new cases reported weekly and conflict disrupting care and surveillance. Cross-border spread remains a risk. Care Access: Cuban deportee Yasmany Moreno says he and others in Bangui have fallen ill, alleging malaria and difficulty getting treatment; the claims have not been independently confirmed. Yellow Fever: WHO counted two cases in the Central African Republic among 67 confirmed across nine African countries, and warns that uneven vaccination and cross-border movement could fuel spread. Food and Nutrition: A $7 million Catholic Relief Services project supported 21,000 Central Africans with food, livestock and training, but its leaders warn that shrinking aid threatens such assistance. Preparedness: The latest phase of a regional health security programme includes CAR, aiming to strengthen disease surveillance and coordination across borders.
Yellow Fever: The Central African Republic recorded two confirmed cases in a nine-country African outbreak that had reached 67 cases and 18 deaths by October 12, WHO reported. Cross-border movement, mosquitoes and uneven vaccination coverage could fuel further spread; WHO rated the regional risk moderate. Regional Preparedness: The CAR is among four countries in the third phase of the Health Security Programme for Western and Central Africa, launched November 3. The initiative aims to improve disease surveillance and coordination on health emergencies. Ebola Response: Insecurity in eastern Democratic Republic of the Congo has forced health teams to suspend outbreak work after contacts fled an observation centre, complicating efforts to trace infections and contain the disease.
Travel Health: The U.S. placed the Central African Republic among 11 African countries under its highest “Do Not Travel” warning, citing serious risks and limited emergency assistance; travellers should also consider access to medical care. Yellow Fever: WHO reported two confirmed cases in CAR, with no deaths, as nine African countries recorded 67 cases and 18 deaths through October 12. WHO rates the regional risk as moderate and warns that cross-border movement and gaps in vaccination could drive further spread. Regional Preparedness: A new phase of the West and Central Africa Health Security Programme includes CAR and aims to strengthen disease surveillance, cooperation and readiness for health emergencies.
Regional Outbreaks: The DRC has reported more than 60,000 cholera cases and 1,800 deaths this year. Insecurity in the east is also disrupting Ebola response work: a health centre was destroyed and teams suspended operations after contacts fled an observation site. Yellow Fever: WHO counted 67 cases and 18 deaths across nine African countries through October 12, including two cases in the Central African Republic, with no deaths reported there. WHO warns that uneven vaccination and cross-border movement could fuel spread. Preparedness: The third phase of the regional Health Security Programme includes CAR and aims to strengthen disease surveillance and coordination for health emergencies.
Travel Health Alert: The United States has placed the Central African Republic among 11 African countries under its highest “Do Not Travel” warning, citing risks that include health threats and limited access to emergency assistance. Yellow Fever: WHO reports 67 confirmed cases and 18 deaths across nine African countries from January to October; the CAR recorded two cases and no deaths. WHO says cross-border movement, mosquitoes and uneven vaccination coverage could fuel further spread. Ebola Preparedness: Africa CDC reports more than 10,600 cases and 5,200 deaths in the ongoing multi-country outbreak, with concern over spread in the DRC and gaps in response readiness. Regional Response: The third phase of the West and Central Africa Health Security Programme includes the CAR and aims to strengthen cross-border cooperation, disease surveillance and emergency response.
Regional Disease Risks: A U.S. travel advisory issued November 9 flagged Ebola and other health risks in Uganda and the Democratic Republic of the Congo, alongside security concerns. The outbreak remains a regional threat, but the reports do not identify the Central African Republic as affected by Ebola. Yellow Fever: WHO recorded two confirmed cases in the Central African Republic, with no deaths, among 67 cases and 18 deaths across nine African countries through October 12. It warned that cross-border movement and gaps in vaccination could fuel spread; regional risk is moderate. Health Preparedness: The Central African Republic is among four countries covered by the new phase of a West and Central African health security programme, which aims to strengthen disease surveillance, coordination and emergency response. Rehabilitation Care: The country also joined a regional conference on expanding training in prosthetics and orthotics, a field facing major workforce gaps across Africa.
Yellow Fever: WHO reports two confirmed cases in the Central African Republic among 67 cases and 18 deaths across nine African countries through October 12. Cross-border travel and uneven vaccination coverage could fuel spread; WHO rates the regional risk as moderate. Health Preparedness: The third phase of the West and Central Africa Health Security Programme includes the CAR, aiming to strengthen disease surveillance, cross-border cooperation and emergency response. HIV Prevention: The FDA has tentatively approved the first generic long-acting injectable lenacapavir for prevention, with supplies expected to begin reaching eligible low- and middle-income countries by year’s end. The planned price is $40 per person annually.
Yellow Fever: The Central African Republic recorded two cases among 67 confirmed across nine African countries, with 18 deaths overall, WHO reported. Cross-border travel and uneven vaccination coverage could fuel further spread. Ebola Preparedness: CAR is checking travellers at its border with the DRC as the regional outbreak grows. The country is also part of HeSP Phase III, a regional effort to strengthen disease surveillance and coordinate health emergency responses. HIV Prevention: The FDA has tentatively approved the first generic long-acting injectable lenacapavir for HIV prevention. Initial supplies are expected before year-end, with broader availability in 2027 for eligible low- and middle-income countries, including CAR.
Yellow Fever: WHO says nine African countries recorded 67 confirmed cases and 18 deaths through Oct. 12. The Central African Republic reported two cases and no deaths. Uneven vaccination and cross-border movement could fuel further spread. Regional Preparedness: The third phase of the West and Central Africa Health Security Programme includes CAR, aiming to strengthen disease surveillance, cross-border coordination and emergency response. HIV Prevention: The FDA has granted tentative approval to the first generic long-acting injectable lenacapavir for HIV prevention. Initial supplies are expected before year-end, with broader availability in 2027 across 120 low- and middle-income countries.
Yellow Fever: WHO reports two confirmed cases in the Central African Republic among 67 cases and 18 deaths across nine African countries through Oct. 12. Cross-border travel, mosquitoes and uneven vaccination could fuel spread; the regional risk is moderate. Regional Preparedness: The third phase of the West and Central Africa Health Security Programme includes CAR, with plans to strengthen disease surveillance, emergency response and cooperation across borders. Ebola Readiness: CAR has stepped up checks on travelers at its border with the Democratic Republic of the Congo as Ebola spreads in the region. Africa CDC has urged countries to close preparedness gaps, including in infection control and case management. HIV Prevention: The first generic long-acting injectable lenacapavir for HIV prevention has received U.S. FDA tentative approval. It is intended for 120 lower-income countries, including CAR, with an announced price of $40 per person annually; initial supplies are expected by year-end.
Yellow Fever: WHO reports two confirmed cases in the Central African Republic, part of 67 cases and 18 deaths across nine African countries through Oct. 12. Cross-border travel, uneven vaccination and mosquito exposure raise the risk of further spread; WHO rates the regional threat as moderate. Regional Preparedness: The third phase of the West and Central Africa Health Security Programme includes the CAR and aims to strengthen disease surveillance, cooperation and emergency response across borders. HIV Prevention: The US FDA has tentatively approved the first generic long-acting injectable lenacapavir for HIV prevention. Initial supplies are expected before year-end, with wider availability in 2027; the agreed price is $40 per person annually in 120 eligible countries. Ebola Monitoring: As the major Bundibugyo outbreak spreads in the region, CAR health workers are screening travellers at the DRC border, including temperature checks and registration.
Yellow Fever: WHO reports 67 confirmed cases and 18 deaths across nine African countries, including two cases in the Central African Republic. Cross-border travel, mosquitoes and gaps in vaccination coverage could fuel spread; WHO rates regional risk as moderate. Ebola Preparedness: Africa CDC praised Kenya’s containment efforts but warned of continued spread in the DRC and readiness gaps. A new regional health security programme involving the CAR aims to improve disease surveillance and cross-border response. HIV Prevention: The FDA has tentatively approved the first generic long-acting injectable lenacapavir. The CAR is among 120 lower-income countries covered by a planned price of US$40 per person annually; initial supplies are expected by year’s end, with broader availability in 2027.
Yellow Fever: WHO reports two confirmed cases in the Central African Republic, with no deaths, as nine African countries recorded 67 cases and 18 deaths by Oct. 12. It warns that uneven vaccination and cross-border movement could fuel spread. Regional Preparedness: The third phase of the West and Central Africa Health Security Programme includes CAR, aiming to strengthen disease surveillance, emergency response and cooperation with neighboring countries. HIV Prevention: The FDA has tentatively approved the first generic long-acting injectable lenacapavir for HIV prevention. The $40-per-person annual price is intended for 120 lower-income countries, including CAR, with initial supplies expected by year-end. Health Cooperation: CAR and Russia signed agreements on infectious-disease prevention and emergency response, alongside plans for medical staff training, maternal and child health, medicine oversight and health technology.
Regional Health Security: The third phase of the West and Central Africa Health Security Programme launched in Brazzaville on Nov. 3, with the Central African Republic among participating countries. The initiative aims to strengthen cross-border cooperation, disease surveillance and emergency response. Ebola Preparedness: With more than 10,000 confirmed cases and nearly 5,000 deaths reported in the DRC outbreak, CAR is screening travelers at river crossings along its porous border. African health ministers have urged countries to keep borders open while increasing surveillance and coordination. HIV Prevention: The FDA has granted tentative approval to the first generic long-acting injectable lenacapavir for HIV prevention. Priced at $40 per person annually for 120 eligible low- and middle-income countries, initial supplies are expected by year-end. Health Cooperation: CAR and Russia signed agreements to cooperate on infectious-disease prevention and response, medical training, maternal and child health, medicine oversight and healthcare digitalization.
Regional Preparedness: The third phase of the West and Central Africa Health Security Programme includes the Central African Republic, aiming to strengthen disease surveillance, cross-border cooperation and emergency response. Ebola Screening: With the outbreak spreading in neighboring DR Congo, CAR has stepped up health checks at river crossings, including handwashing, temperature screening and traveler registration. African health ministers have agreed to keep borders open while coordinating surveillance. HIV Prevention: The US FDA has tentatively approved the first generic long-acting injectable lenacapavir for HIV prevention. Initial supplies are expected by year-end, with wider availability in 2027 for eligible low- and middle-income countries. Health Cooperation: CAR and Russia signed two health memorandums covering infectious-disease prevention, outbreak response, medical training, maternal and child health, and medicines oversight.
Regional Health Security: The Republic of the Congo has launched Phase III of the West and Central Africa Health Security Programme, which includes CAR and aims to strengthen cross-border cooperation and disease surveillance. Rehabilitation Training: CAR is among eight countries taking part in a regional meeting in Togo on expanding prosthetics and orthotics training, as access to rehabilitation remains limited across Africa. HIV Prevention: The first generic long-acting injectable lenacapavir for HIV prevention has received U.S. FDA tentative approval. It is priced at $40 per person per year for 120 eligible low- and middle-income countries, with initial supplies expected by year’s end. Ebola Preparedness: CAR continues daily screening of travelers arriving from the DRC, including handwashing, temperature checks and registration at Bangui’s M’Poko Bac pier. African health ministers have agreed to keep borders open while strengthening surveillance and coordination as the outbreak spreads. Health Cooperation: CAR and Russia signed agreements covering infectious-disease prevention, outbreak response, medical training, maternal and child health, and medicine oversight.
Regional Health Security: The third phase of the West and Central Africa Health Security Programme launched in Brazzaville, with the Central African Republic among the countries covered. Its priorities include stronger cross-border cooperation and disease surveillance. Ebola Preparedness: With the deadly Bundibugyo outbreak still spreading in the region, CAR is screening travellers at the Oubangui River crossing with handwashing, temperature checks and registration. African health ministers have agreed to keep borders open while strengthening surveillance and coordination. HIV Prevention: The FDA has tentatively approved the first generic long-acting injectable lenacapavir for HIV prevention. At a planned price of $40 per person per year in 120 low- and middle-income countries, it could widen access, though supplies are expected to arrive gradually. Health Partnerships: CAR and Russia signed agreements on infectious-disease prevention and response, medical training, maternal and child health, and medicine oversight. Rehabilitation Care: CAR joined a regional conference in Togo focused on training prosthetics and orthotics professionals, as access to rehabilitation remains limited across Africa.
HIV Prevention: The FDA has tentatively approved the first generic long-acting injectable lenacapavir for HIV prevention. Priced at $40 per person annually for eligible low- and middle-income countries, initial supplies are expected by year-end, with wider availability in 2027. Ebola Preparedness: With the DRC outbreak exceeding 10,000 confirmed cases and nearly 5,000 deaths in an October 28 report, the CAR is screening travelers crossing the Oubangui River, including handwashing, temperature checks and registration. African health ministers have agreed to keep borders open while strengthening surveillance and coordination. Health Cooperation: The CAR and Russia signed agreements on infectious-disease prevention and epidemic response, as well as medical staff training, maternal and child health, medicine oversight and health technology.
HIV Prevention: The FDA has tentatively approved the first generic long-acting injectable lenacapavir, with initial supplies expected by year-end and wider availability in 2027. The lower-cost version could expand access in eligible countries, including potentially the Central African Republic. Ebola Readiness: With the outbreak in neighboring DRC exceeding 10,000 confirmed cases and nearly 5,000 deaths, CAR is conducting daily health checks at river crossings, including handwashing, temperature screening and traveler registration. African health ministers have opted to keep borders open while strengthening surveillance and coordination. Health Cooperation: CAR and Russia signed agreements to work together on infectious-disease prevention and outbreak response, as well as training health workers, maternal and child health, medicine oversight and healthcare technology.
Sign up for:
Central African Republic Health Digest
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.